Should a patient wait before taking Flexeril (cyclobenzaprine) and tramadol after receiving Toradol (ketorolac)?

No Mandatory Waiting Period Required Between Toradol and Flexeril/Tramadol

You can take Flexeril (cyclobenzaprine) and tramadol after Toradol (ketorolac) without a required waiting period, but be aware of important safety considerations for each medication.

Key Safety Considerations

Tramadol After Toradol

• No pharmacokinetic interaction exists between ketorolac (an NSAID) and tramadol (an atypical opioid)
• These medications work through different mechanisms and can be given sequentially or even together
• Research demonstrates that ketorolac-tramadol combinations are used safely in clinical practice 1, 2
• However, tramadol carries significant risks: increased GI adverse events (OR 6.72) and neurologic adverse events including dizziness, drowsiness, and sedation 3
• Tramadol should be used cautiously due to marked variability in drug metabolism and risk of seizures, particularly in patients ≥75 years or those with hepatic/renal dysfunction 4

Flexeril (Cyclobenzaprine) After Toradol

• No interaction between ketorolac and cyclobenzaprine requires a waiting period
• Cyclobenzaprine is structurally related to tricyclic antidepressants and acts as a centrally acting muscle relaxant 5
• Critical warning: Cyclobenzaprine has anticholinergic effects causing drowsiness, confusion, constipation, and urinary retention 5
• Can be taken on the same day as ketorolac without timing restrictions

Critical Drug Interaction Warning: Tramadol + Cyclobenzaprine

If taking both tramadol AND cyclobenzaprine together, there is serious risk of serotonin syndrome 4, 6, 7.

Serotonin Syndrome Risk

• Tramadol has serotonin reuptake inhibition properties 4
• Cyclobenzaprine, being structurally similar to tricyclic antidepressants, also has serotonergic activity 6
• Case reports document severe serotonin syndrome from cyclobenzaprine combined with other serotonergic drugs, with symptoms starting within hours 6, 7
• Symptoms include: autonomic instability, severe agitation, confusion, hyperthermia, muscle rigidity

The 2025 NCCN guidelines explicitly state: "Tramadol and tapentadol should be used with caution or avoided in patients taking other serotonergic medications (eg, tricyclic antidepressants) due to risk of serotonin syndrome" 4

Practical Clinical Algorithm

If prescribed both tramadol and cyclobenzaprine after ketorolac:

1. Strongly consider using only ONE of these medications, not both simultaneously
2. If both are deemed necessary, patients require close monitoring for serotonin syndrome manifestations
3. Educate patients on warning signs: agitation, confusion, rapid heart rate, high fever, muscle stiffness, tremor

Timing from ketorolac:

• No waiting period needed before starting either medication
• Ketorolac's analgesic effect lasts 4-6 hours 8
• Can transition immediately to tramadol or cyclobenzaprine as pain management requires

Additional Safety Considerations

Sedation Risk

Both tramadol and cyclobenzaprine cause significant CNS depression:

• Avoid operating machinery or driving when taking either medication 9
• Combined sedative effects are additive when used together
• Neurologic adverse events (drowsiness, dizziness) are common with both agents 3, 5

GI Effects

• Tramadol significantly increases GI adverse events (nausea, vomiting) compared to placebo 3
• Ketorolac carries GI bleeding risk, but this doesn't interact with tramadol or cyclobenzaprine pharmacologically
• The 5-day maximum duration for ketorolac should already be completed before long-term use of other analgesics 8

Common Pitfall to Avoid

Do not assume muscle relaxants and weak opioids are "safe" combinations - the serotonin syndrome risk from tramadol plus cyclobenzaprine is real and potentially life-threatening 6, 7. This combination should be avoided unless absolutely necessary with appropriate monitoring.